We report here the synthesis, the biological evaluation and the molecular modeling studies of new imidazo[1,2-a]pyridinesderivatives designed as potent kinase inhibitors. This collection was obtained from 2-aminopyridines and 2-bromoacetophenone which afforded final compound in only one step. The bioactivity of this family of new compounds was tested using protein kinase and ATP competition assays